HSV-1-induced SOCS-1 expression in keratinocytes: Use of a SOCS-1 antagonist to block a novel mechanism of viral immune evasion

Journal of Immunology

Volumn 183, Issue 2, 2009, Pages 1253-1262

  Frey, Kenneth G ^a   Ahmed, Chulbul M I ^c   Dabelic, Rea ^c   Jager, Lindsey D ^c   Noon Song, Ezra N ^c   Haider, S Mohammad ^c   Johnson, Howard M ^c   Bigley, Nancy J ^a,b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GAMMA INTERFERON; LEUCYLPROLYLGLUTAMINYLASPARTYLLYSYLGLUTAMYLTYROSYLTYROSYLLYSYLVALYLLYSYLGLUTAMYLPROLINE; LUCIFERASE; MESSENGER RNA; STAT1 ALPHA PROTEIN; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; UNCLASSIFIED DRUG; GAMMA INTERFERON ACTIVATION FACTOR; INTERFERON STIMULATED GENE FACTOR 3; PEPTIDE; SOCS1 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; FIBROBLAST; GENE EXPRESSION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 1 INFECTION; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS IMMUNITY; WILD TYPE; DRUG ANTAGONISM; GENETICS; HUMAN; IMMUNITY; IMMUNOLOGY; METABOLISM; PATHOGENICITY; TUMOR CELL LINE; VIROLOGY;

CELL LINE, TUMOR; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNITY; INTERFERON-GAMMA; INTERFERON-STIMULATED GENE FACTOR 3; KERATINOCYTES; PEPTIDES; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 70249096342     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900570     Document Type: Article

References (45)

1. Roizman, B. D., M. Knipe, and R. J. Whitley. 2007. Herpes simplex viruses. In Fields Virology, 3rd ed. D. M. Knipe, and P. M. Howley, eds. Lippincott Williams & Wilkins, Philadelphia, pp. 2501-2602.
2. Diefenbach, R. J., M. Miranda-Saksena, M. W. Douglas, and A. L. Cunningham. 2008. Transport and egress of herpes simplex virus in neurons. Rev. Med. Virol. 18: 35-51.
3. Koelle, D. M., and L. Corey. 2008. Herpes simplex: insights on pathogenesis and possible vaccines. Annu. Rev. Med. 59: 381-395.
4. Cunningham, A. L., R. J. Diefenbach, M. Miranda-Saksena, L. Bosnjak, M. Kim, C. Jones, and M. W. Douglas. 2006. The cycle of human herpes simplex virus infection: virus transport and immune control. J. Infect. Dis. 194: S11-S18.
5. Mikloska, Z., V. A. Danis, S. Adams, A. R. Lloyd, D. L. Adrian, and A. L. Cunningham. 1998. In vivo production of cytokines and beta (C-C) chemokines in human recurrent herpes simplex lesions: do herpes simplex virusinfected keratinocytes contribute to their production? J. Infect. Dis. 177: 827-838.
6. + T cell inhibition of HSV-1 reactivation from neuronal latency. Science 322: 268-271.
7. + T cells and latent herpes simplex virus type 1: keeping the peace in sensory ganglia. Expert Opin. Biol. Ther. 7: 1323-1331.
8. Decman, V., P. R. Kinchington, S. A. Harvey, and R. L. Hendricks. 2005. Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression. J. Virol. 79: 10339-10347.
9. Mossman, K. 2005. Analysis of anti-interferon properties of the herpes simplex virus type 1 ICP0 protein. Methods Mol. Med. 116: 195-205.
10. Arduino, P. G., and S. R. Porter. 2008. Herpes simplex virus type I infection: overview on relevant clinico-pathological features. J. Oral. Pathol. Med. 37: 107-121.
11. Patel, A. R., P. Romanelli, B. Roberts, and R. S. Kirsner. 2007. Treatment of herpes simplex virus infection: rationale for occlusion. Adv. Skin Wound Care 20: 408-412.
12. Burgos, J. S., E. Serrano-Saiz, I. Sastre, and F. Valdivieso. 2006. ICP47 mediates viral neuroinvasiveness by induction of TAP protein following intravenous inoculation of herpes simplex virus 1 in mice. J. Neurovirol. 12: 420-427.
13. + T cell response. J. Exp. Med. 187: 341-348.
14. Chee, A. V., and B. Roizman. 2004. Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites. J. Virol. 78: 4185-4196.
15. Halford, W. P., C. Weisend, J. Grace, M. Soboleski, D. J. Carr, J. W. Balliet, Y. Imai, T. P. Margolis, and B. M. Gebhardt. 2006. ICP0 antagonizes STAT1-dependent repression of herpes simplex virus: implications for the regulation of viral latency. Virology J. 3: 44-49.
16. Edison, K. M., W. E. Hobbs, B. J. Manning, P. Carlson, and N. A. DeLuca. 2002. Expression of herpes simplex virus ICP0 inhibits the induction of interferonstimulated genes by viral infection. J. Virol. 76: 2180-2191.
17. Yokota, S., N. Yokosawa, T. Okabayashi, T. Suzutani, S. Miura, K. Jimbow, and N. Fujii. 2004. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of interferon signaling pathway. J. Virol. 78: 6282-6286.
18. Yoshimura, A., T. Naka, and M. Kubo. 2007. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7: 454-465.
19. Mansell, A., R. Smith, S. L. Doyle, P. Gray, J. E. Fenner, P. J. Crack, S. E. Nicholson, D. J. Hilton, L. A. O'Neill, and P. J. Hertzog. 2006. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat. Immunol. 7: 148-155.
20. Croker, B. A., H. Kiu, and S. E. Nicholson. 2008. SOCS regulation of JAK/STAT signaling pathway. Semin. Cell. Dev. Biol. 19: 414-422.
21. Yasukawa, H., H. Misawa, H. Sakamoto, M. Masuhara, A. Sasaki, T. Wakioka, S. Ohtsuka, T. Imaizumi, T. Matsuda, J. N. Ihle, and A. Yoshimura. 1999. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18: 1309-1320. (Pubitemid 29110315)
22. Dorsky, D. I., and C. S. Crumpacker. 1987. Drugs five years later: acyclovir. Ann. Intern. Med. 107: 859-874.
23. Wald, A., and K. Link. 2002. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J. Infect. Dis. 185: 45-52.
24. Stow, N. D., and E. C. Stow. 1986. Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. J. Gen. Virol. 67: 2571-2585.
25. Szente, B. E., I. J. Weiner, M. J. Jablonsky, N. R. Krishna, B. A. Torres, and H. M. Johnson. 1996. Structural requirements for agonist activity of a murine interferon-γ peptide. J. Interferon Cytokine Res. 16: 813-817.
26. Thiam, K., E. Loing, C. Verwaerde, C. Auriault, and H. Gras-Masse. 1999. IFN-γ-derived lipopeptides: influence of lipid modification on the conformation and the ability to induce MHC class II expression on murine and human cells. J. Med. Chem. 42: 3732-3736.
27. Waiboci, L. W., C. M. Ahmed, M. G. Mujtaba, L. O. Flowers, J. P. Martin, M. I. Haider, and H. M. Johnson. 2007. Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist. J. Immunol. 178: 5058-5068.
28. Ahmed, C. M., and H. M. Johnson. 2006. IFN-γ and its receptor subunit IFNGR1 are recruited to the IFN-γ-activated sequence element at the promoter site of IFN-γ-activated genes: evidence of transactivational activity in IFNGR1. J. Immunol. 177: 315-321.
29. Flowers, L. O., H. M. Johnson, M. G. Mujtaba, M. R. Ellis, S. M. Haider, and P. S. Subramaniam. 2004. Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function. J. Immunol. 172: 7510-7518.
30. Lucet, I. S., E. Fantino, M. Styles, R. Bamert, O. Patel, S. E. Broughton, M. Walter, C. J. Burns, H. Treutlein, A. F. Wilks, and J. Rossjohn. 2006. The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor. Blood 107: 176-183.
31. Poon, A. P., H. Gu, and B. Roizman. 2006. ICP0 and US3 protein kinase of herpes simplex virus 1 independently block histone deacetylation to enable gene expression. Proc. Natl. Acad. Sci. USA 103: 9993-9998.
32. Gu, H., and B. Roizman. 2009. The two functions of herpes simplex virus 1 ICP0, inhibition of silencing by the CoREST/REST/HDAC complex and degradation of PML, are executed in tandem. J. Virol. 83: 181-187.
33. Cliffe, A. R., and D. M. Knipe. 2008. Herpes simplex virus ICP0 promotes both histone removal and acetylation on viral DNA during lytic infection. J. Virol. 82: 12030-12038.
34. Sekulovich, R. E., K. Leary, and R. M. Sandri-Goldin. 1988. The herpes simplex virus type 1 α protein ICP27 can act as a trans-repressor or a trans-activator in combination with ICP4 and ICP0. J. Virol. 62: 4510-4522.
35. Kobayashi, T., G. Takaesu, and A. Yoshimura. 2006. Mal-function of TLRs by SOCS. Nat. Immunol. 7: 123-124.
36. Ahmad, R., S. El Bassam, P. Cordeiro, and J. Menezes. 2008. Requirement of TLR2-mediated signaling for the induction of IL-15 gene expression in human monocytic cells by HSV-1. Blood 112: 2360-2368.
37. Marine, J. C., D. J. Topham, C. McKay, D. Wang, E. Parganas, D. Stravopodis, A. Yoshimura, and J. N. Ihle. 1999. SOCS1 deficiency causes a lymphocytedependent perinatal lethality. Cell 98: 609-616.
38. Starr, R., D. Metcalf, A. G. Elefanty, M. Brysha, T. A. Willson, N. A. Nicola, D. J. Hilton, and W. S. Alexander. 1998. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc. Natl. Acad. Sci. USA 95: 14395-14399.
39. Takaoka, A., Y. Mitani, H. Suemori, M. Sato, T. Yokochi, S. Noguchi, N. Tanaka, and T. Taniguchi. 2000. Cross talk between interferon-α and -α/β signaling components in caveolar membrane domains. Science 288: 2357-2360.
40. Fleischmann, W. R., J. A. Georgiades, L. C. Osborne, and H. M. Johnson. 1979. Potentiation of interferon activity by mixed preparation of fibroblast and immune interferon. Infect. Immun. 26: 248-253.
41. Shen, L., K. Evel-Kabler, R. Strube, and S. Y. Chen. 2004. Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity. Nat. Biotechnol. 22: 1546-1553.
42. Song, X. T., K. Evel-Kabler, M. Aldrich, F. Gao, X. F. Huang, and S. Y. Chen, S. Y. 2006. An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells. PLoS Med. 3: e11.
43. Mahller, Y. Y., B. Sakthivel, W. H. Baird, B. J. Aronow, Y. Hsu, T. P. Cripe, and R. Mehrian-Shai. 2008. Molecular analysis of human cancer cells infected by an oncolytic HSV-1 reveals multiple upregulated cellular genes and a role for SOCS1 in virus replication. Cancer Gene Ther. 15: 733-741.
44. Todo, T. 2008. Oncolytic virus therapy using genetically engineered simplex viruses. Front. Biosc. 13: 2060-2064.
45. Pothlichet, J., M. Chignard, and M. Si-Tahar. 2008. Cutting edge: innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-1/IFNAR1-dependent pathway. J. Immunol. 180: 2034-2038.